Related Experiment Video
Updated: Mar 26, 2026
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Evaluating the Cost-effectiveness of Catheter Ablation of Atrial Fibrillation
Andrew Y Chang1, Daniel Kaiser1, Aditya Ullal2
1Department of Medicine, Stanford University School of Medicine, Stanford, California.
Insights
Atrial fibrillation (AF) catheter ablation is a cost-effective first-line therapy compared to drug treatment. It improves quality of life and reduces healthcare utilization for patients with AF.
Area of Science:
- Cardiology
- Health Economics
Background:
- Atrial fibrillation (AF) is a common cardiac condition with significant morbidity, mortality, and healthcare costs.
- Catheter ablation is a recommended first-line therapy for AF, proving more effective than antiarrhythmic drugs in maintaining sinus rhythm.
Purpose of the Study:
- To present a primer on cost-effectiveness analysis (CEA) for AF ablation.
- To review existing data on the cost-effectiveness of AF ablation.
- To identify areas for future research in AF ablation cost-effectiveness.
Main Methods:
- Review of cost-effectiveness analysis (CEA) principles.
- Synthesis of published data on AF ablation cost-effectiveness.
- Identification of research gaps.
Main Results:
- Catheter ablation demonstrates favorable cost-effectiveness compared to antiarrhythmic drug therapy for atrial fibrillation.
- Ablation offers long-term benefits in quality of life and reduced healthcare utilization.
- The cost-effectiveness evaluation must balance upfront costs with long-term patient outcomes.
Conclusions:
- Catheter ablation is a valuable therapeutic option for atrial fibrillation, offering significant long-term benefits.
- Further research is needed to fully elucidate the economic value and optimize strategies for AF ablation.
- Cost-effectiveness analysis is crucial for understanding the value of AF ablation in healthcare settings.
Abstract:
Atrial fibrillation (AF) is one of the most common cardiac conditions treated in primary care and specialty cardiology settings, and is associated with considerable morbidity, mortality and cost. Catheter ablation, typically by electrically isolating the pulmonary veins and surrounding tissue, is more effective at maintaining sinus rhythm than conventional antiarrhythmic drug therapy and is now recommended as first-line therapy. From a value standpoint, the cost-effectiveness of ablation must incorporate the upfront procedural costs and risks with the benefits of longer term improvements in quality of life (QOL) and healthcare utilisation. Here, we present a primer on cost-effectiveness analysis (CEA), review the data on cost-effectiveness of AF ablation and outline key areas for further investigation.
Related Concept Videos
01:28Cardiac Catheterization I: Pre-Procedure Overview
01:24Cardiac Catheterization III: Left Heart Catheterization
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias